GEDi Cube and Renovaro Biosciences enter into an agreement

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

GEDi Cube Intl Ltd., an AI medical technology company, and Renovaro Biosciences Inc. (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). If completed, the Transaction will result in […]

Quanterix launches LucentAD biomarker test to aid early Diagnosis of Alzheimer’s Disease

Test will play an important role in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer’s disease

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, yesterday announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD). The LucentAD test, which will be available to healthcare providers as an aid in […]

Carota partners with Drimaes to introduce OTA into smart control solutions

Carota, a prominent provider of global OTA upgrades, remote diagnosis, and fleet solutions, has entered a partnership with Drimaes, a Korean company specialized in smart mobility solutions. The agreement aims to introduce OTA functionality into smart control solutions for vehicles, enhance existing software and hardware ecosystem, and provide feature solutions such as Fleet Management System (FMS), […]